← Leaderboards
John P Devincenzo
University Of Tennessee Health Sci Ctr
$2,118,879
Attributed
$3,601,212
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $617.7K · FY2005–14$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$3,601,212 · 3
By mechanism
R01$2,964,667 · 1
K23$580,215 · 1
M01$56,330 · 1
Top collaborators
- Julia L Hurwitz5 shared
Most similar at University Of Tennessee Health Sci Ctr
Same institution · by research overlap
- James Martin Krueger$18,958,539
- Colleen B Jonsson$31,118,426
Others in their field
Top investigators on “Virus Infection Mechanism”
- Barton F Haynes · Duke University$301,883,505
- Carol Nesel · Westat$147,274,423
- Barbara Driver · Westat, Inc.$106,807,093
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Louis J. Picker · Oregon Health And Science University$56,748,176
- Dan H. Barouch · Fred Hutchinson Cancer Center$56,523,101
Research focus
Virus Infection MechanismHuman SubjectInfant Human (0-1 Year)Preschool Child (1-5)Respiratory Syncytial VirusClinical ResearchPathologic ProcessAntiviral AgentsTumor Necrosis Factor AlphaVirus ReplicationRespiratory Disorder ChemotherapyTissue /Cell CultureInterferon GammaVirus GeneticsImmunogeneticsPediatric PharmacologyGenotypeHistocompatibility AntigensGenetic PolymorphismHuman Therapy EvaluationDisease /Disorder Proneness /RiskGenetic RegulationHospital UtilizationCessation Of Life
Grant awards (12)
Influence of maternal antibodies on a Sendai virus-vectored RSV vaccine$566,924
R01 · FY2014 · AI
Influence of maternal antibodies on a Sendai virus-vectored RSV vaccine$586,166
R01 · FY2013 · AI
Influence of maternal antibodies on a Sendai virus-vectored RSV vaccine$617,512
R01 · FY2012 · AI
Influence of maternal antibodies on a Sendai virus-vectored RSV vaccine$617,720
R01 · FY2011 · AI
Influence of maternal antibodies on a Sendai virus-vectored RSV vaccine$576,345
R01 · FY2010 · AI
MECHANISMS OF RESPIRATORY SYNCYTIAL VIRUS (RSV) PATHOGENESIS$23,633
M01 · FY2005 · RR
IMMUNOGENETICS AND THE PATHOGENESIS OF RSV INFECTION$116,043
K23 · FY2004 · RR
Mechanisms of Respiratory Syncytial Virus (RSV) Pathogenesis$32,697
M01 · FY2004 · RR
IMMUNOGENETICS AND THE PATHOGENESIS OF RSV INFECTION$116,043
K23 · FY2003 · RR
IMMUNOGENETICS AND THE PATHOGENESIS OF RSV INFECTION$116,043
K23 · FY2002 · RR
IMMUNOGENETICS AND THE PATHOGENESIS OF RSV INFECTION$116,043
K23 · FY2001 · RR
IMMUNOGENETICS AND THE PATHOGENESIS OF RSV INFECTION$116,043
K23 · FY2000 · RR